$ACFN
ACORN ENERGY, INC. Stock $acfn

$acfn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224030676 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$3.050M	$2.275M
YoY Change	46.14%	15.31%
Cost Of Revenue	$863.0K	$610.0K
YoY Change	60.71%	26.29%
Gross Profit	$2.187M	$1.665M
YoY Change	41.1%	11.74%
Gross Profit Margin	71.7%	73.19%
Selling, General & Admin	$1.197M	$1.181M
YoY Change	-10.0%	-3.12%
% of Gross Profit	54.73%	70.93%
Research & Development	$234.0K	$226.0K
YoY Change	10.38%	20.21%
% of Gross Profit	10.7%	13.57%
Depreciation & Amortization	$33.00K	$30.00K
YoY Change	-19.51%	-21.05%
% of Gross Profit	1.51%	1.8%
Operating Expenses	$1.431M	$1.407M
YoY Change	-7.2%	0.0%
Operating Profit	$756.0K	$258.0K
YoY Change	9350.0%	210.84%
Interest Expense	$20.00K	$18.00K
YoY Change	0.0%	12.5%
% of Operating Profit	2.65%	6.98%
Other Income/Expense, Net
YoY Change
Pretax Income	$776.0K	$276.0K
YoY Change	2774.07%	178.79%
Income Tax	$42.00K
% Of Pretax Income	5.41%
Net Earnings	$725.0K	$271.0K
YoY Change	2920.83%	182.29%
Net Earnings / Revenue	23.77%	11.91%
Basic Earnings Per Share	$0.29	$0.11
Diluted Earnings Per Share	$0.29	$0.11
COMMON SHARES
Basic Shares Outstanding	2.487M shares	2.487M shares
Diluted Shares Outstanding	2.511M shares	2.507M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.153M	$1.463M
YoY Change	26.65%	-6.99%
Cash & Equivalents	$2.153M	$1.463M
Short-Term Investments
Other Short-Term Assets	$318.0K	$392.0K
YoY Change	-7.29%	-1.51%
Inventory	$659.0K	$731.0K
Prepaid Expenses
Receivables	$894.0K	$540.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.531M	$3.734M
YoY Change	1.27%	-14.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$527.0K	$552.0K
YoY Change	-13.61%	-10.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$99.00K	$118.0K
YoY Change	-52.63%	-47.32%
Total Long-Term Assets	$872.0K	$1.035M
YoY Change	-48.13%	-43.04%
TOTAL ASSETS
Total Short-Term Assets	$4.531M	$3.734M
Total Long-Term Assets	$872.0K	$1.035M
Total Assets	$5.403M	$4.769M
YoY Change	-12.22%	-23.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$313.0K	$288.0K
YoY Change	-29.5%	-10.28%
Accrued Expenses	$202.0K	$123.0K
YoY Change	59.06%	-21.66%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.254M	$4.157M
YoY Change	-14.7%	-13.05%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$23.00K	$22.00K
YoY Change	21.05%	22.22%
Total Long-Term Liabilities	$23.00K	$22.00K
YoY Change	-98.9%	-99.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.254M	$4.157M
Total Long-Term Liabilities	$23.00K	$22.00K
Total Liabilities	$5.089M	$5.202M
YoY Change	-28.08%	-27.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$100.1M	-$100.8M
YoY Change	-1.13%	-0.44%
Common Stock	$103.4M	$103.4M
YoY Change	0.07%	0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.036M	$3.036M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$288.0K	-$451.0K
YoY Change
Total Liabilities & Shareholders Equity	$5.403M	$4.769M
YoY Change	-12.22%	-23.19%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$725.0K	$271.0K
YoY Change	2920.83%	182.29%
Depreciation, Depletion And Amortization	$33.00K	$30.00K
YoY Change	-19.51%	-21.05%
Cash From Operating Activities	$698.0K	$84.00K
YoY Change	232.38%	-64.71%
INVESTING ACTIVITIES
Capital Expenditures	$4.000K	$38.00K
YoY Change	-86.67%	245.45%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$4.000K	-$38.00K
YoY Change	-86.67%	245.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	698.0K	84.00K
Cash From Investing Activities	-4.000K	-38.00K
Cash From Financing Activities	0.000	0.000
Net Change In Cash	694.0K	46.00K
YoY Change	285.56%	-79.74%
FREE CASH FLOW
Cash From Operating Activities	$698.0K	$84.00K
Capital Expenditures	$4.000K	$38.00K
Free Cash Flow	$694.0K	$46.00K
YoY Change	285.56%	-79.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2485000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2487000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	42000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2487307	shares
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	50178	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	ACFN	Deferred Charges Sale Of Equipment Additions DeferredChargesSaleOfEquipmentAdditions		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33886
	dei	Entity Registrant Name EntityRegistrantName	ACORN ENERGY, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-2786081
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 N West Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wilmington
	dei	Entity Address State Or Province EntityAddressStateOrProvince	DE
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19801
	dei	City Area Code CityAreaCode	770
	dei	Local Phone Number LocalPhoneNumber	209-0012
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2487307	shares
CY2023Q4	us-gaap	Cash Cash	1449000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	536000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	962000	usd
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	809000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	280000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4036000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	570000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	193000	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	476000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	174000	usd
CY2023Q4	us-gaap	Assets Assets	5449000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	288000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	132000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	ACFN	Decrease Increase In Provision For Credit Loss DecreaseIncreaseInProvisionForCreditLoss		usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	ACFN	Share Based Compensation Arrangement By Share Based Payment Award Option Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	ACFN	Deferred Charges Sale Of Equipment Additions DeferredChargesSaleOfEquipmentAdditions		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33886
	dei	Entity Registrant Name EntityRegistrantName	ACORN ENERGY, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-2786081
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 N West Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wilmington
	dei	Entity Address State Or Province EntityAddressStateOrProvince	DE
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19801
	dei	City Area Code CityAreaCode	770
	dei	Local Phone Number LocalPhoneNumber	209-0012
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2487307	shares
CY2023Q4	us-gaap	Cash Cash	1449000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	540000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	536000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	962000	usd
CY2024Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	608000	usd
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	809000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	392000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	280000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	3734000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4036000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	570000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	139000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	193000	usd
CY2024Q2	us-gaap	Deferred Costs DeferredCosts	226000	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	476000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	118000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1219000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1407000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	83000	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	96000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-826000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	68000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	174000	usd
CY2024Q2	us-gaap	Assets Assets	4769000	usd
CY2023Q4	us-gaap	Assets Assets	5449000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	288000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	288000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	123000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	132000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3590000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4034000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	123000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	30000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4607000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1550000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	98000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	6275000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2537485	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2534969	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	25000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	103321000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101148000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	50178	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3036000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-838000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	12000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-826000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5449000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	483000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1074000	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-826000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-719000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	276000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-433000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1011000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-84000	usd
CY2023Q1	ACFN	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	5000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1074000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4034000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	123000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	29000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	30000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4157000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4607000	usd
CY2024Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	990000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1550000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	33000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	98000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	22000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	5202000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	6275000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	42000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2534969	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2484791	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	25000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	25000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	103372000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	103321000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100812000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101148000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	50178	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3036000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-451000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-838000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	18000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	12000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-433000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-826000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4769000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5449000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4407000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2275000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1151000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	610000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	188000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1219000	usd
	us-gaap	Gross Profit GrossProfit	2806000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1665000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1490000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	464000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	402000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	226000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	188000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2456000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2416000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1181000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1219000	usd
	us-gaap	Operating Expenses OperatingExpenses	2920000	usd
	us-gaap	Operating Expenses OperatingExpenses	2818000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	1407000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	258000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	83000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	33000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	27000	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	369000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	276000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	usd
	us-gaap	Profit Loss ProfitLoss	344000	usd
	us-gaap	Profit Loss ProfitLoss	15000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	276000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000	usd
	us-gaap	Net Income Loss NetIncomeLoss	336000	usd
	us-gaap	Net Income Loss NetIncomeLoss	11000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	271000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	96000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q1	us-gaap	Profit Loss ProfitLoss	68000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-826000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-719000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	276000	usd
	us-gaap	Operating Expenses OperatingExpenses	2920000	usd
	us-gaap	Operating Expenses OperatingExpenses	2818000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1407000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	258000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	83000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	33000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	27000	usd
CY2024Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18000	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	369000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	276000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	usd
	us-gaap	Profit Loss ProfitLoss	15000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	276000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000	usd
	us-gaap	Net Income Loss NetIncomeLoss	336000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	271000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	96000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
CY2024Q1	us-gaap	Profit Loss ProfitLoss	68000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-719000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	276000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-433000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1011000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-84000	usd
CY2023Q1	ACFN	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	5000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1074000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1074000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-963000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-719000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	276000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-433000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1011000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-84000	usd
CY2023Q1	ACFN	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	5000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1074000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-963000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-963000	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
	us-gaap	Profit Loss ProfitLoss	344000	usd
	us-gaap	Profit Loss ProfitLoss	15000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76000	usd
	ACFN	Decrease Increase In Provision For Credit Loss DecreaseIncreaseInProvisionForCreditLoss	-7000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8000	usd
	ACFN	Noncash Lease Expense NoncashLeaseExpense	64000	usd
	ACFN	Noncash Lease Expense NoncashLeaseExpense	63000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	38000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	104000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-212000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	22000	usd
	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	-451000	usd
	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	-44000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	56000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	119000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1004000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	196000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-71000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-67000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-10000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	35000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	155000	usd
	us-gaap	Payments For Software PaymentsForSoftware	36000	usd
	us-gaap	Payments For Software PaymentsForSoftware	37000	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	4000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-433000	usd
CY2023Q1	ACFN	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	5000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1074000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1074000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13000	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
	us-gaap	Profit Loss ProfitLoss	344000	usd
	us-gaap	Profit Loss ProfitLoss	15000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76000	usd
	ACFN	Decrease Increase In Provision For Credit Loss DecreaseIncreaseInProvisionForCreditLoss	-7000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	19000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8000	usd
	ACFN	Noncash Lease Expense NoncashLeaseExpense	64000	usd
	ACFN	Noncash Lease Expense NoncashLeaseExpense	63000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	38000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	104000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-212000	usd
	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	-451000	usd
	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	-44000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	56000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	119000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1004000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	196000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-71000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-67000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	35000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	155000	usd
	us-gaap	Payments For Software PaymentsForSoftware	36000	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	4000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1449000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1450000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1463000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1573000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	usd
	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	2000	usd
	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	2000	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
CY2023Q2	us-gaap	Profit Loss ProfitLoss	99000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-963000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-963000	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
	us-gaap	Profit Loss ProfitLoss	344000	usd
	us-gaap	Profit Loss ProfitLoss	15000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76000	usd
	ACFN	Decrease Increase In Provision For Credit Loss DecreaseIncreaseInProvisionForCreditLoss	-7000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	19000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8000	usd
	ACFN	Noncash Lease Expense NoncashLeaseExpense	64000	usd
	ACFN	Noncash Lease Expense NoncashLeaseExpense	63000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	38000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	104000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-212000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	22000	usd
	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	-451000	usd
	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	-44000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	56000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	119000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1004000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	196000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-71000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-67000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	35000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	155000	usd
	us-gaap	Payments For Software PaymentsForSoftware	36000	usd
	us-gaap	Payments For Software PaymentsForSoftware	37000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	123000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1449000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1450000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1463000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1573000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	2000	usd
	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	2000	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	347	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
	us-gaap	Profit Loss ProfitLoss	344000	usd
	us-gaap	Profit Loss ProfitLoss	15000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	76000	usd
	ACFN	Decrease Increase In Provision For Credit Loss DecreaseIncreaseInProvisionForCreditLoss	-7000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	19000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8000	usd
	ACFN	Noncash Lease Expense NoncashLeaseExpense	64000	usd
	ACFN	Noncash Lease Expense NoncashLeaseExpense	63000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	38000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	104000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	22000	usd
	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	-451000	usd
	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	-44000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	56000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	119000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1004000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-71000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-67000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	35000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	155000	usd
	us-gaap	Payments For Software PaymentsForSoftware	36000	usd
	us-gaap	Payments For Software PaymentsForSoftware	37000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	123000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1449000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1450000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1463000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1573000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	usd
	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	2000	usd
	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	2000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	347	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	123000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1449000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1450000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1463000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1573000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	usd
	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	2000	usd
	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	2000	usd
CY2023Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-16
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	347	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zmbRJ6GtbBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Concentrations of Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and trade accounts receivable. The Company’s cash was deposited with a U.S. bank and amounted to $<span id="xdx_907_eus-gaap--DepositAssets_iI_c20240630_zaxICmxP76de" title="Deposits assets">1,463,000</span> at June 30, 2024. The Company does not believe there is a significant risk of non-performance by its counterparties. For the six- and three-month periods, one customer </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">represented <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zmdLDyeJaINi" title="Concentration risk percentage">10</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zlge0Shdwaff" title="Concentration risk percentage">12</span>% of the Company’s total invoiced sales, respectively. <span style="background-color: white">At June 30, 2024, the Company did not have any customers that represented <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--TwoCustomerMember_zSN7jfFgQ7gc" title="Concentration risk percentage">10</span>% or </span>greater of our total accounts receivable. Approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--TwoCustomerMember_z5tQ4a1qWWw2" title="Concentration risk percentage">25</span>% of the accounts receivable at December 31, 2023 <span style="background-color: white">was due from one customer which was subsequently collected in full. Credit risk with respect to the balance of trade receivables is generally diversified due to the number of entities comprising the Company’s customer base. Although we do not believe there is significant risk of non-performance by these counterparties, any failures or defaults on their part could negatively impact the value of our financial instruments and could have a material adverse effect on our business, operations or financial condition.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q2	us-gaap	Deposit Assets DepositAssets	1463000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	347	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zznKMa1VHcR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Use of Estimates in Preparation of Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of unaudited condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zmbRJ6GtbBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Concentrations of Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and trade accounts receivable. The Company’s cash was deposited with a U.S. bank and amounted to $<span id="xdx_907_eus-gaap--DepositAssets_iI_c20240630_zaxICmxP76de" title="Deposits assets">1,463,000</span> at June 30, 2024. The Company does not believe there is a significant risk of non-performance by its counterparties. For the six- and three-month periods, one customer </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">represented <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zmdLDyeJaINi" title="Concentration risk percentage">10</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zlge0Shdwaff" title="Concentration risk percentage">12</span>% of the Company’s total invoiced sales, respectively. <span style="background-color: white">At June 30, 2024, the Company did not have any customers that represented <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--TwoCustomerMember_zSN7jfFgQ7gc" title="Concentration risk percentage">10</span>% or </span>greater of our total accounts receivable. Approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--TwoCustomerMember_z5tQ4a1qWWw2" title="Concentration risk percentage">25</span>% of the accounts receivable at December 31, 2023 <span style="background-color: white">was due from one customer which was subsequently collected in full. Credit risk with respect to the balance of trade receivables is generally diversified due to the number of entities comprising the Company’s customer base. Although we do not believe there is significant risk of non-performance by these counterparties, any failures or defaults on their part could negatively impact the value of our financial instruments and could have a material adverse effect on our business, operations or financial condition.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q2	us-gaap	Deposit Assets DepositAssets	1463000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	26000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zmbRJ6GtbBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Concentrations of Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and trade accounts receivable. The Company’s cash was deposited with a U.S. bank and amounted to $<span id="xdx_907_eus-gaap--DepositAssets_iI_c20240630_zaxICmxP76de" title="Deposits assets">1,463,000</span> at June 30, 2024. The Company does not believe there is a significant risk of non-performance by its counterparties. For the six- and three-month periods, one customer </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">represented <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zmdLDyeJaINi" title="Concentration risk percentage">10</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zlge0Shdwaff" title="Concentration risk percentage">12</span>% of the Company’s total invoiced sales, respectively. <span style="background-color: white">At June 30, 2024, the Company did not have any customers that represented <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--TwoCustomerMember_zSN7jfFgQ7gc" title="Concentration risk percentage">10</span>% or </span>greater of our total accounts receivable. Approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--TwoCustomerMember_z5tQ4a1qWWw2" title="Concentration risk percentage">25</span>% of the accounts receivable at December 31, 2023 <span style="background-color: white">was due from one customer which was subsequently collected in full. Credit risk with respect to the balance of trade receivables is generally diversified due to the number of entities comprising the Company’s customer base. Although we do not believe there is significant risk of non-performance by these counterparties, any failures or defaults on their part could negatively impact the value of our financial instruments and could have a material adverse effect on our business, operations or financial condition.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q2	us-gaap	Deposit Assets DepositAssets	1463000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	26000	shares
	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	8.13
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15000	shares
CY2024Q2	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	9.17
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50000	shares
	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	7.20
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	58000	shares
CY2023Q2	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	6.89
	us-gaap	Net Income Loss NetIncomeLoss	336000	usd
	us-gaap	Net Income Loss NetIncomeLoss	11000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	271000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	96000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2487000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2484000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zmbRJ6GtbBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Concentrations of Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and trade accounts receivable. The Company’s cash was deposited with a U.S. bank and amounted to $<span id="xdx_907_eus-gaap--DepositAssets_iI_c20240630_zaxICmxP76de" title="Deposits assets">1,463,000</span> at June 30, 2024. The Company does not believe there is a significant risk of non-performance by its counterparties. For the six- and three-month periods, one customer </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">represented <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zmdLDyeJaINi" title="Concentration risk percentage">10</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zlge0Shdwaff" title="Concentration risk percentage">12</span>% of the Company’s total invoiced sales, respectively. <span style="background-color: white">At June 30, 2024, the Company did not have any customers that represented <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--TwoCustomerMember_zSN7jfFgQ7gc" title="Concentration risk percentage">10</span>% or </span>greater of our total accounts receivable. Approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--TwoCustomerMember_z5tQ4a1qWWw2" title="Concentration risk percentage">25</span>% of the accounts receivable at December 31, 2023 <span style="background-color: white">was due from one customer which was subsequently collected in full. Credit risk with respect to the balance of trade receivables is generally diversified due to the number of entities comprising the Company’s customer base. Although we do not believe there is significant risk of non-performance by these counterparties, any failures or defaults on their part could negatively impact the value of our financial instruments and could have a material adverse effect on our business, operations or financial condition.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q2	us-gaap	Deposit Assets DepositAssets	1463000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	26000	shares
	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	8.13
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15000	shares
CY2024Q2	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	9.17
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50000	shares
	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	7.20
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	58000	shares
CY2023Q2	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	6.89
	us-gaap	Net Income Loss NetIncomeLoss	336000	usd
	us-gaap	Net Income Loss NetIncomeLoss	11000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	271000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	96000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2487000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2484000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	26000	shares
	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	8.13
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15000	shares
CY2024Q2	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	9.17
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50000	shares
	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	7.20
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	58000	shares
CY2023Q2	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	6.89
	us-gaap	Net Income Loss NetIncomeLoss	336000	usd
	us-gaap	Net Income Loss NetIncomeLoss	11000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	271000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	96000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2487000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2484000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2485000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	14000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	20000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2501000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2486000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2507000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2487000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1463000	usd
CY2024Q2	ACFN	Working Capital WorkingCapital	-423000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1463000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3590000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1004000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13000	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	545000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	8.13
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15000	shares
CY2024Q2	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	9.17
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50000	shares
	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	7.20
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	58000	shares
CY2023Q2	ACFN	Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice	6.89
	us-gaap	Net Income Loss NetIncomeLoss	336000	usd
	us-gaap	Net Income Loss NetIncomeLoss	11000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	271000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	96000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2487000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2484000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2487000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2485000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	14000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	20000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2501000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2486000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2507000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q2	ACFN	Working Capital WorkingCapital	-423000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1463000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3590000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13000	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	545000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2487000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2485000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	14000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	20000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2501000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2486000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2507000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1463000	usd
CY2024Q2	ACFN	Working Capital WorkingCapital	-423000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1463000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3590000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1004000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13000	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	545000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-7000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-2000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	2000	usd
CY2024Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2487000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2485000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	14000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	20000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2501000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2507000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2487000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1463000	usd
CY2024Q2	ACFN	Working Capital WorkingCapital	-423000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1463000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3590000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1004000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13000	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	545000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-7000	usd
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	2000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-2000	usd
CY2024Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-7000	usd
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	2000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-2000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	2000	usd
CY2024Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	683000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	904000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	48000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	58000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	731000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	962000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	160000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-7000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-2000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	683000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	904000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	48000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	58000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	731000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	962000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
	ACFN	Cash Paid For Operating Lease Liabilities CashPaidForOperatingLeaseLiabilities	64000	usd
	ACFN	Cash Paid For Operating Lease Liabilities CashPaidForOperatingLeaseLiabilities	63000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	683000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	904000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	58000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	731000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	962000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	160000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
	ACFN	Cash Paid For Operating Lease Liabilities CashPaidForOperatingLeaseLiabilities	64000	usd
	ACFN	Cash Paid For Operating Lease Liabilities CashPaidForOperatingLeaseLiabilities	63000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	904000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	48000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	58000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	731000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	962000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
	ACFN	Cash Paid For Operating Lease Liabilities CashPaidForOperatingLeaseLiabilities	64000	usd
	ACFN	Cash Paid For Operating Lease Liabilities CashPaidForOperatingLeaseLiabilities	63000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M
	ACFN	Cash Paid For Operating Lease Liabilities CashPaidForOperatingLeaseLiabilities	64000	usd
	ACFN	Cash Paid For Operating Lease Liabilities CashPaidForOperatingLeaseLiabilities	63000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	33000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	164000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	160000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	127000	usd
CY2021Q3	us-gaap	Sublease Income SubleaseIncome	2375	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	3000	usd
	ACFN	Sublease Profit Paid SubleaseProfitPaid	16000	usd
CY2021Q3	ACFN	Annual Service Cost AnnualServiceCost	2220	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due Next Twelve Months FinanceLeaseLiabilitySubleasePaymentsDueNextTwelveMonths	29000	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due Year Two FinanceLeaseLiabilitySubleasePaymentsDueYearTwo	7000	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due FinanceLeaseLiabilitySubleasePaymentsDue	36000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	131000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	33000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	164000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	160000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	127000	usd
CY2021Q3	us-gaap	Sublease Income SubleaseIncome	2375	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	3000	usd
	ACFN	Sublease Profit Paid SubleaseProfitPaid	16000	usd
CY2021Q3	ACFN	Annual Service Cost AnnualServiceCost	2220	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due Next Twelve Months FinanceLeaseLiabilitySubleasePaymentsDueNextTwelveMonths	29000	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due Year Two FinanceLeaseLiabilitySubleasePaymentsDueYearTwo	7000	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due FinanceLeaseLiabilitySubleasePaymentsDue	36000	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2537485	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2487307	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	71893	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.41
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	40000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7900	shares
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	33000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	164000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	160000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	127000	usd
CY2021Q3	us-gaap	Sublease Income SubleaseIncome	2375	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	3000	usd
	ACFN	Sublease Profit Paid SubleaseProfitPaid	16000	usd
CY2021Q3	ACFN	Annual Service Cost AnnualServiceCost	2220	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due Next Twelve Months FinanceLeaseLiabilitySubleasePaymentsDueNextTwelveMonths	29000	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due Year Two FinanceLeaseLiabilitySubleasePaymentsDueYearTwo	7000	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due FinanceLeaseLiabilitySubleasePaymentsDue	36000	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2537485	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2487307	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	71893	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.41
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	40000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7900	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.08
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	131000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	164000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	160000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	127000	usd
CY2021Q3	us-gaap	Sublease Income SubleaseIncome	2375	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3000	usd
	ACFN	Sublease Profit Paid SubleaseProfitPaid	16000	usd
CY2021Q3	ACFN	Annual Service Cost AnnualServiceCost	2220	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due Next Twelve Months FinanceLeaseLiabilitySubleasePaymentsDueNextTwelveMonths	29000	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due Year Two FinanceLeaseLiabilitySubleasePaymentsDueYearTwo	7000	usd
CY2024Q2	ACFN	Finance Lease Liability Sublease Payments Due FinanceLeaseLiabilitySubleasePaymentsDue	36000	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2537485	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2487307	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	71893	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.41
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	40000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7900	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.08
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2812	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.12
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2537485	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2487307	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	71893	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.41
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	40000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7900	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.08
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2812	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.12
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	76981	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	258000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	68038	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.45
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M24D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	227000	usd
	ACFN	Fair Value Of Options Granted FairValueOfOptionsGranted	47000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.941	pure
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	31000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4407000	usd
	us-gaap	Gross Profit GrossProfit	3256000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58000	usd
	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	903000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722000	usd
	us-gaap	Gross Profit GrossProfit	2806000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	76000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2275000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1665000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.08
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2812	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.12
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	76981	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	258000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	68038	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.45
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M24D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	227000	usd
	ACFN	Fair Value Of Options Granted FairValueOfOptionsGranted	47000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.941	pure
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	31000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4407000	usd
	us-gaap	Gross Profit GrossProfit	3256000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58000	usd
	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	903000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722000	usd
	us-gaap	Gross Profit GrossProfit	2806000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	76000	usd
	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	490000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2275000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1665000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30000	usd
CY2024Q2	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	505000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1490000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38000	usd
CY2023Q2	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	339000	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2812	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.12
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	76981	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	258000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	68038	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.45
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M24D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	227000	usd
	ACFN	Fair Value Of Options Granted FairValueOfOptionsGranted	47000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.941	pure
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	31000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4407000	usd
	us-gaap	Gross Profit GrossProfit	3256000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58000	usd
	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	903000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722000	usd
	us-gaap	Gross Profit GrossProfit	2806000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	76000	usd
	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	490000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2275000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1665000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30000	usd
CY2024Q2	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	505000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1490000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38000	usd
CY2023Q2	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	339000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	76981	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	258000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	68038	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.45
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M24D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	227000	usd
	ACFN	Fair Value Of Options Granted FairValueOfOptionsGranted	47000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.941	pure
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	31000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4407000	usd
	us-gaap	Gross Profit GrossProfit	3256000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58000	usd
	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	903000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722000	usd
	us-gaap	Gross Profit GrossProfit	2806000	usd
	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	490000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2275000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1665000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1490000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38000	usd
CY2023Q2	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	339000	usd
	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	903000	usd
	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	490000	usd
CY2024Q2	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	505000	usd
CY2023Q2	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	339000	usd
	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	534000	usd
CY2024Q2	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	505000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1490000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38000	usd
CY2023Q2	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	339000	usd
	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	903000	usd
	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	490000	usd
CY2024Q2	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	505000	usd
CY2023Q2	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	339000	usd
	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	534000	usd
	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	475000	usd
CY2024Q2	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	229000	usd
CY2023Q2	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	240000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	369000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	276000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4407000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2275000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5584000	usd
	ACFN	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	2235000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4580000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year One ContractWithCustomerLiabilityRevenueAdditionsInYearOne	3590000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year Two ContractWithCustomerLiabilityRevenueAdditionsInYearTwo	982000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year Three ContractWithCustomerLiabilityRevenueAdditionsInYearThree	8000	usd
	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	903000	usd
	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	490000	usd
CY2024Q2	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	505000	usd
CY2023Q2	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	339000	usd
	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	534000	usd
	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	475000	usd
CY2024Q2	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	229000	usd
CY2023Q2	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	240000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	369000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	276000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4407000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5584000	usd
	ACFN	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	2235000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4580000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year One ContractWithCustomerLiabilityRevenueAdditionsInYearOne	3590000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year Two ContractWithCustomerLiabilityRevenueAdditionsInYearTwo	982000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year Three ContractWithCustomerLiabilityRevenueAdditionsInYearThree	8000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4580000	usd
	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	903000	usd
	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	490000	usd
CY2024Q2	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	505000	usd
CY2023Q2	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	339000	usd
	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	534000	usd
	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	475000	usd
CY2024Q2	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	229000	usd
CY2023Q2	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	240000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	369000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	276000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2275000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5584000	usd
	ACFN	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	2235000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-3239000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4580000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year One ContractWithCustomerLiabilityRevenueAdditionsInYearOne	3590000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year Two ContractWithCustomerLiabilityRevenueAdditionsInYearTwo	982000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year Three ContractWithCustomerLiabilityRevenueAdditionsInYearThree	8000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4580000	usd
CY2024Q2	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	229000	usd
CY2023Q2	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	240000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	369000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	276000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4407000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2275000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1973000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5584000	usd
	ACFN	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	2235000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-3239000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4580000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year One ContractWithCustomerLiabilityRevenueAdditionsInYearOne	3590000	usd
	ACFN	Contract With Customer Liability Revenue Additions In Year Three ContractWithCustomerLiabilityRevenueAdditionsInYearThree	8000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4580000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4580000	usd
CY2023Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1285000	usd
	ACFN	Deferred Charges Sale Of Equipment Recognized DeferredChargesSaleOfEquipmentRecognized	-451000	usd
CY2024Q2	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	834000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year One DeferredChargesSaleOfEquipmentInYearOne	608000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year Two DeferredChargesSaleOfEquipmentInYearTwo	224000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment DeferredChargesSaleOfEquipment	834000	usd
CY2023Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	364000	usd
	ACFN	Contract With Customer Asset Additions ContractWithCustomerAssetAdditions	21000	usd
	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	112000	usd
CY2023Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1285000	usd
CY2024Q2	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	834000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year One DeferredChargesSaleOfEquipmentInYearOne	608000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year Two DeferredChargesSaleOfEquipmentInYearTwo	224000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year Three DeferredChargesSaleOfEquipmentInYearThree	2000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment DeferredChargesSaleOfEquipment	834000	usd
CY2023Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	364000	usd
	ACFN	Contract With Customer Asset Additions ContractWithCustomerAssetAdditions	21000	usd
	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	112000	usd
CY2024Q2	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	273000	usd
CY2023Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1285000	usd
	ACFN	Deferred Charges Sale Of Equipment Recognized DeferredChargesSaleOfEquipmentRecognized	-451000	usd
CY2024Q2	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	834000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year One DeferredChargesSaleOfEquipmentInYearOne	608000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year Two DeferredChargesSaleOfEquipmentInYearTwo	224000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year Three DeferredChargesSaleOfEquipmentInYearThree	2000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment DeferredChargesSaleOfEquipment	834000	usd
CY2023Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	364000	usd
	ACFN	Contract With Customer Asset Additions ContractWithCustomerAssetAdditions	21000	usd
	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	112000	usd
CY2024Q2	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	273000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year One ContractWithCustomerLiabilitySalesCommissionsExpenseInYearOne	167000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year Two ContractWithCustomerLiabilitySalesCommissionsExpenseInYearTwo	82000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year Three ContractWithCustomerLiabilitySalesCommissionsExpenseInYearThree	24000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense ContractWithCustomerLiabilitySalesCommissionsExpense	273000	usd
CY2023Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1285000	usd
	ACFN	Deferred Charges Sale Of Equipment Recognized DeferredChargesSaleOfEquipmentRecognized	-451000	usd
CY2024Q2	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	834000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year One DeferredChargesSaleOfEquipmentInYearOne	608000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year Two DeferredChargesSaleOfEquipmentInYearTwo	224000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment In Year Three DeferredChargesSaleOfEquipmentInYearThree	2000	usd
CY2024Q2	ACFN	Deferred Charges Sale Of Equipment DeferredChargesSaleOfEquipment	834000	usd
CY2023Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	364000	usd
	ACFN	Contract With Customer Asset Additions ContractWithCustomerAssetAdditions	21000	usd
	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	112000	usd
CY2024Q2	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	273000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year One ContractWithCustomerLiabilitySalesCommissionsExpenseInYearOne	167000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year Two ContractWithCustomerLiabilitySalesCommissionsExpenseInYearTwo	82000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year Three ContractWithCustomerLiabilitySalesCommissionsExpenseInYearThree	24000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense ContractWithCustomerLiabilitySalesCommissionsExpense	273000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year One ContractWithCustomerLiabilitySalesCommissionsExpenseInYearOne	167000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year Two ContractWithCustomerLiabilitySalesCommissionsExpenseInYearTwo	82000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year Three ContractWithCustomerLiabilitySalesCommissionsExpenseInYearThree	24000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense ContractWithCustomerLiabilitySalesCommissionsExpense	273000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year One ContractWithCustomerLiabilitySalesCommissionsExpenseInYearOne	167000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense In Year Two ContractWithCustomerLiabilitySalesCommissionsExpenseInYearTwo	82000	usd
CY2024Q2	ACFN	Contract With Customer Liability Sales Commissions Expense ContractWithCustomerLiabilitySalesCommissionsExpense	273000	usd

Files In Submission

Name	View Source	Status
acfn-20240630_cal.xml	Edgar Link	unprocessable
0001493152-24-030676-index-headers.html	Edgar Link	pending
0001493152-24-030676-index.html	Edgar Link	pending
0001493152-24-030676.txt	Edgar Link	pending
0001493152-24-030676-xbrl.zip	Edgar Link	pending
acfn-20240630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
acfn-20240630_def.xml	Edgar Link	unprocessable
acfn-20240630_lab.xml	Edgar Link	unprocessable
acfn-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
0001493152-24-030676-index-headers.html	Edgar Link	pending
0001493152-24-030676-index.html	Edgar Link	pending
0001493152-24-030676.txt	Edgar Link	pending
0001493152-24-030676-xbrl.zip	Edgar Link	pending
acfn-20240630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
acfn-20240630_def.xml	Edgar Link	unprocessable
acfn-20240630_lab.xml	Edgar Link	unprocessable
acfn-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
acfn-20240630_cal.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACFN
ACORN ENERGY, INC. Stock $acfn

2024 Q3 Form 10-Q Financial Statement

#000149315224030676 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACFN ACORN ENERGY, INC. Stock $acfn

2024 Q3 Form 10-Q Financial Statement

#000149315224030676 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACFN
ACORN ENERGY, INC. Stock $acfn